Rocket Pharmaceuticals (RCKT) Times Interest Earned (2014 - 2026)
Rocket Pharmaceuticals (RCKT) posted Times Interest Earned of -$102.56 for Q1 2026, down 10.35% sequentially from -$92.95 in Q4 2025, and up 24.82% YoY from -$82.17 in Q1 2025.
Powered by 
Analysis
Rocket Pharmaceuticals (RCKT) Times Interest Earned (2014 - 2026) Analysis & Trends
Rocket Pharmaceuticals has reported Times Interest Earned for 13 years, with the latest figure at -$102.56 in Q1 2026.
- Quarterly Times Interest Earned rose 24.82% year-over-year to -$102.56 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$114.16 (up 20.28% YoY) and the FY2025 annual result came in at -$1.74, up 17.73% from the prior year.
- Times Interest Earned slipped to -$102.56 in Q1 2026 per RCKT's latest filing, from -$92.95 in the prior quarter.
- Over five years, Times Interest Earned peaked at -$0.5 in Q1 2022 and troughed at -$156.5 in Q2 2024.
- A 5-year average of -$70.6 and a median of -$92.95 in 2025 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2024 and 2025: Times Interest Earned sank 28536.42% in 2024, then jumped 99.25% in 2025.
- Over 5 years, Times Interest Earned stood at -$147.93 in 2022, then increased by 8.98% to -$134.64 in 2023, then climbed by 1.55% to -$132.55 in 2024, then advanced by 29.88% to -$92.95 in 2025, then fell by 10.35% to -$102.56 in 2026.
- According to Business Quant data, Times Interest Earned over the past three periods registered -$102.56, -$92.95, and -$1.1 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -493.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -21.24 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 8.18 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 2.82 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 1.42 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.08 |
| 10 | Rocket Pharmaceuticals | 437.27 Mn | 437.27 Mn | - | -99.20 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -99.20 |
| Mar 31, 2026 | -102.56 |
| Dec 31, 2025 | -92.95 |
| Sep 30, 2025 | -110.46 |
| Jun 30, 2025 | -150.42 |
| Mar 31, 2025 | -136.42 |
| Dec 31, 2024 | -132.55 |
| Sep 30, 2024 | -147.40 |
| Jun 30, 2024 | -156.50 |
| Mar 31, 2024 | -143.05 |
| Dec 31, 2023 | -134.64 |
| Sep 30, 2023 | -139.51 |
| Jun 30, 2023 | -146.92 |
| Mar 31, 2023 | -132.89 |
| Dec 31, 2022 | -147.93 |
| Sep 30, 2022 | -125.78 |
| Jun 30, 2022 | -116.58 |
| Mar 31, 2022 | -91.73 |
| Dec 31, 2021 | -95.75 |
| Sep 30, 2021 | -92.97 |